MDxHealth SA (CIK: 0001872529) EDGAR, Information, Filings... CompaniesBIO.Com

MDxHealth SA

Mailing address
CAP BUSINESS CENTER, RUE D'ABHOOZ, 31, B-4040, HERSTAL, Belgium, 00000
Phone
949-271-9221
State location
Belgium
State of incorporation
Belgium
Fiscal year end
N/A
SIC
8071 - (CF Office: Office of Life Sciences) SERVICES-MEDICAL LABORATORIES
Filings
N/A

MDxHealth SA (CIK: 0001872529) is an American company incorporated in the state of Belgium. Head office is located at CAP BUSINESS CENTER, RUE D'ABHOOZ, 31, B-4040, HERSTAL, Belgium, 00000. Work in the industry 8071 - (CF Office: Office of Life Sciences) SERVICES-MEDICAL LABORATORIES. MDxHealth SA is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
MVM Partners, LLC	0001947083	Feb-03-2023	10 percent owner
MVM Partners LLP	0001893459	Nov-04-2021	10 percent owner

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by MDxHealth SA

Filings	Format	Description	Filed/Effective	File/Film Number
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-25-021363 (34 Act) Size: KB	Mar-07-2025	001-40996 25717667
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-25-017449 (34 Act) Size: KB	Feb-26-2025	001-40996 25670675
SCHEDULE 13G/A	Document	Acc-no: 0001420506-25-000431 (34 Act) Size: KB	Feb-13-2025	005-93034 25622570
SCHEDULE 13G/A	Document	Acc-no: 0000935836-25-000142 (34 Act) Size: KB	Feb-13-2025	005-93034 25619785
SCHEDULE 13G/A	Document	Acc-no: 0001535264-25-000007 (34 Act) Size: KB	Feb-07-2025	005-93034 25602743
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-25-003001 (34 Act) Size: KB	Jan-13-2025	001-40996 25526405
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001535264-24-000058 (34 Act) Size: KB	Nov-14-2024	005-93034 241460850
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-095023 (34 Act) Size: KB	Nov-06-2024	001-40996 241431754
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-091717 (34 Act) Size: KB	Oct-29-2024	001-40996 241405684
SC 13D/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Acc-no: 0002039852-24-000027 (34 Act) Size: KB	Oct-28-2024	005-93034 241400305
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000935836-24-000622 (34 Act) Size: KB	Oct-04-2024	005-93034 241355636
SC 13G	Document	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001124140-24-000075 (34 Act) Size: KB	Oct-04-2024	005-93034 241354851
SCHEDULE 13G/A	Document	Acc-no: 0001781002-24-000048 (34 Act) Size: KB	Oct-03-2024	005-93034 241351813
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-083354 (34 Act) Size: KB	Sep-30-2024	001-40996 241339549
424B5	Document	Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0001213900-24-081940 (33 Act) Size: KB	Sep-26-2024	333-268885 241326100
424B5	Document	Prospectus filed pursuant to Rule 424(b)(5) Acc-no: 0001213900-24-081808 (33 Act) Size: KB	Sep-25-2024	333-268885 241324220
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-071457 (34 Act) Size: KB	Aug-21-2024	001-40996 241228873
EFFECT	Document	Acc-no: 9999999995-24-002118 (33 Act) Size: KB	Jul-10-2024	333-280606 241110970
CORRESP	Document	A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001213900-24-059813 ( Act) Size: KB	Jul-08-2024
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001213900-24-059810 (34 Act) Size: KB	Jul-08-2024	001-40996 241104698

Recent 20 filings. View all MDxHealth SA filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Where is MDxHealth SA's headquarters?

MDxHealth SA is located in CAP BUSINESS CENTER, RUE D'ABHOOZ, 31, B-4040, HERSTAL, Belgium, 00000.

What is the MDxHealth SA's website?

MDxHealth SA's website is unknown

Who invested in MDxHealth SA?

Updating!

How much funding has MDxHealth SA raised to date?

Updating!

When was the last funding round for MDxHealth SA?

Updating!

When was MDxHealth SA founded?

Updating!

MDxHealth SA overview
MDxHealth SA job
MDxHealth SA stock
MDxHealth SA ownership
MDxHealth SA CEO
MDxHealth SA documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

MDxHealth SA

Information

Mailing address

Phone

State location

State of incorporation

Fiscal year end

SIC

Filings

About MDxHealth SA

Ownership

Stock Chart

Jobs

Recent SEC Filings

Reviews

Samuel Ejimofor

Ryan Storey

Catherine

Frequently Asked Questions

Tags:

MDxHealth SA

Information

Mailing address

Phone

State location

State of incorporation

Fiscal year end

SIC

Filings

About MDxHealth SA

Ownership

Stock Chart

Jobs

Recent SEC Filings

Reviews

Samuel Ejimofor

Ryan Storey

Catherine

Frequently Asked Questions

Tags:

Orther Companies

Update: Feb 21, 2025

Update: May 23, 2023

Update: May 16, 2023

Update: Apr 26, 2023

Update: Aug 25, 2022

Update: Aug 25, 2022

Latest News